Rise Life Science Corp (RLSC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 11-2015 | 11-2014 | 11-2013 | 11-2012 | 11-2011 | |
| Sales | 9 | 12 | 88 | 127 | 0 |
| Cost of Goods | N/A | 163 | 14 | N/A | 0 |
| Gross Profit | N/A | -151 | 74 | N/A | 0 |
| Operating Expenses | 1,950 | 2,441 | 3,080 | 2,522 | 1,417 |
| Operating Income | -1,941 | -2,592 | -3,006 | -2,395 | -1,417 |
| Interest Expense | 412 | 347 | 495 | 315 | 246 |
| Other Income | -933 | 1,025 | 1 | 13 | 1,663 |
| Pre-tax Income | -3,286 | -1,914 | -3,500 | -2,698 | N/A |
| Net Income Continuous | -3,286 | -1,914 | -3,500 | -2,698 | -1,617 |
| Net Income | $-3,286 | $-1,914 | $-3,500 | $-2,698 | $-1,617 |
| EPS Basic Total Ops | -20.00 | -30.00 | -85.00 | -75.00 | -50.00 |
| EPS Basic Continuous Ops | -20.00 | -30.00 | -85.00 | -75.00 | -50.00 |
| EPS Diluted Total Ops | -20.00 | -30.00 | -85.00 | -75.00 | -50.00 |
| EPS Diluted Continuous Ops | -20.00 | -30.00 | -85.00 | -75.00 | -50.00 |
| EBITDA(a) | $-2,727 | $-1,240 | $-2,777 | $-2,347 | $-1,377 |